Amgen's Perlmutter joins Immune Design board
This article was originally published in Scrip
Executive Summary
Immune Design Corp has appointed Dr Roger Perlmutter to its board of directors. Until earlier this year, Dr Perlmutter served as executive vice-president of research and development at Amgen.